Radiotherapy Market Will Hit At A CAGR Of 4.7% By 2025

Radiotherapy Market Research Report 2020, Size, Growth, Share, Trends and Industry Analysis by Type [External Beam Radiation Therapy (Intensity Modulated Radiation Therapy, Image Guided Radiation Therapy, Tomotherapy, Stereotactic Radio Surgery, Stereotactic Body Radiation Therapy, and Proton Therapy), Internal Radiation Therapy and Systemic Radiation Therapy], Application (Skin and Lip Cancer, Head and Neck Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Spine Cancer, and others), Equipment (Linear Accelerators, Radiation Therapy Simulators and Treatment Planning Systems), End-User (Hospitals and Independent Radiotherapy Centers) and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa) - Global Forecast till 2025

Radiotherapy Market Scenario

Radiotherapy or Radiation therapy refers to treating conditions, such as cancer and non-cancerous tumors, thyroid, and disorders related to the blood using high-energy rays. It is largely used in cancer treatment and less commonly in the procedures of thyroid disease, blood disorders, and non-cancerous growths. Owing to its proven efficacy in the cancer treatments, radiotherapy witnesses a massive uptake.

Subsequently, this helps to increase the size of its market. Further, technological advancements in medical science & biotechnology that have improved the outlook for cancer treatments are escalating the market on the global platform, controlling the spread of the disease sufficiently.

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/1526

According to a leading research firm, Market Research Future (MRFR), the global radiotherapy market is poised to touch a valuation of USD 7 MN by 2023. In its recently published research report, MRFR also asserts that the market would register over 7% CAGR throughout the estimated period (2017 - 2023). In 2016, the market had valued at 4.5 MN, which indicates that the market is expected to achieve almost a double-fold growth over the next six years.

Cancer cases are increasing pervasively, becoming a paramount concern, globally. Improving economy that is increasing the access to quality care, is on the other hand, increasing the access to the modern life that is leading to the growing addictions, such as tobacco and alcoholism, a dominant risk factor developing cancer cells and tumors.

Additionally, increasing per capita healthcare expenditures, increasing population, exposures to harmful radiation, heredity reasons, and genetic mutations are some of the key factors driving the growth of the radiotherapy market. Increasing governmental initiatives are supporting the growth of the market, spreading awareness about cancer and its treatments.

On the flip side, high costs associated with the radiotherapy, long approval time for the clinical trials along with the adverse effects associated with therapy are obstructing the market growth. Nevertheless, unavailability of comprehensive procedures, especially in the developing regions, are expected to support the growth of the market, offering plenty of growth opportunities to the market players. Also, substantial investments in the R&D to bring more novelty and betterments in the radiology presage the broad scope for the market to evolve further over the review period.

Global Radiotherapy Market - Segmentations

The report is segmented into three key market dynamics to widen the scope of understanding,

By Treatment Type: Proton Therapy & X-rays and External Beam Radiotherapy (Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), Stereotactic Radio Surgery, 3D Conformal Radiation Therapy, Tomotherapy, and Stereotactic Body Radiation Therapy.), others.

By Application: Breast Cancer, Prostate Cancer, Lung Cancer, and others.

By Regions: Europe, North America, Asia Pacific, and the Rest-of-the-World.

Global Radiotherapy Market - Regional Analysis

North America would continue with its leading position in the global Radiotherapy market, slicing the largest market share. Majorly supported by the US, the growth in the market is fostered by the increasing prevalence of various types of cancer and thyroid as a result of the consequences of the wrong lifestyle, in the region. Moreover, technological advances, coupled with the increasing healthcare expenditure, support the growth of the regional market.

The Radiotherapy market in the European region is expected to account for the second-largest market, following the North American market closely. Factors boosting the regional market growth include technological advancement and the augmented adoption of radiotherapy to treat the growing cases of cancer occurrences.

The Asia Pacific region, heading with the improving economic conditions that are rapidly increasing the access to the quality of healthcare, is rapidly emerging as a profitable market for radiotherapy. Moreover, the increasing number of cancer patients in the region, alongside the advancements in medical technology, drives the market growth in the region.

Global Radiotherapy Market - Competitive Analysis

Highly competitive, the radiotherapy market appears to be fragmented, characterized by the presence of a number of well-established players. These players incorporate strategic initiatives, such as acquisition, collaboration, expansion, and technology launch, to gain a competitive advantage in the market.

Players increasingly invest in R&D to develop a cost-effective product portfolio. They seek expansion through various strategic initiatives. They tap the growing markets for expansions and strive to address the critical needs of the market with a broad range of effective solutions and comprehensive workflow.

Major Players:

Players leading the global Radiotherapy market include Siemens (Germany), Varian (India), GE Healthcare (UK), Cardinal Health (US), Nordion (CA), Isoray (US), View ray (US), Fuji Holdings (Japan), Philips Healthcare (US), Shimadzu Corporation (Japan), and Hologic (US) among others.

Industry/ Innovation/Related News:

January 14, 2019 --- MIM Software Inc. (the US), a leading global provider of medical imaging software solutions in the fields of radiation brachytherapy, announced the receiving of FDA 510(k) clearance for its molecular radiotherapy (MRT) dosimetry. This effective form of therapy uses radiopharmaceuticals such as Lutathera (Lu-177 DOTATATE) and Azedra (I-131 iobenguane) to target tumors based on specific receptors.

Table Of Contents:

Chapter 1. Radiotherapy Market Report Prologue

Chapter 2. Radiotherapy Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Radiotherapy Market Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Radiotherapy Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

Chapter 5. Radiotherapy Market Factor Analysis

....Continued

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/radiotherapy-market-1526

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

This release was published on openPR.